IPP Bureau
USFDA inspects Lupin's Mandideep Unit-1 facility
By IPP Bureau - November 25, 2022
The inspection of the facility resulted in issuance of a Form-483 with eight observations each for the Drug Product facility and API facility at the site
Laurus Labs takes stake in Ethan Energy India
By IPP Bureau - November 25, 2022
This will enable the company to consume 100% of the solar energy to be supplied by Ethan Energy India Private Limited from their 10 MW Solar Energy plant
Neuland Laboratories appoints Abhijit Majumdar as CFO
By IPP Bureau - November 24, 2022
He brings over 30 years of experience across various organizations such as Asian Paints PPG, Berger Paints, Tata Steel, among others
USFDA issues warning letter to Glenmark's Goa manufacturing facility
By IPP Bureau - November 24, 2022
The company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility
Biocon enters commercialization agreement with Zentiva
By IPP Bureau - November 24, 2022
Under the terms of this agreement Biocon will be responsible for the manufacturing and supply of Liraglutide to Zentiva, for its commercialization across 30 countries in Europe
Zydus receives final approval from USFDA for Famotidine Injection
By IPP Bureau - November 24, 2022
Famotidine Injection is indicated to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed
Evive enters license agreement with Acrotech Biopharma to commercialize Ryzneuta in US
By IPP Bureau - November 24, 2022
Ryzneuta is a novel dimeric G- CSF long-acting fusion protein without pegylation. The Biologics License Application (BLA) of Ryzneuta is currently under late-stage review by the US FDA for Chemotherapy-Induced Neutropenia (CIN)
BHL announces inauguration of Opium Processing Business at Savli
By IPP Bureau - November 24, 2022
The new production line is equipped with the latest advanced manufacturing system to produce quality products of Alkaloids & APIs used in a wide range of pharmaceutical applications
Reforms in Ayush to boost growth: Sarbananda Sonowal
By IPP Bureau - November 24, 2022
Ayush market has reached US $18 billion from meager US $3 billion under guidance and visionary leadership of our Prime Minister
Centre deploys three teams to manage high measles cases among children
By IPP Bureau - November 24, 2022
The teams will assist the state health authorities in instituting public health measures and facilitate operationalization of requisite control and containment measures
Dr. Bharti Pawar to participate in Global Conference on Antimicrobial Resistance
By IPP Bureau - November 24, 2022
The conference is also expected to pave the way for nations to come out with bold and specific political commitments in the 2024 UN General Assembly High-Level Meeting on AMR
SRL Diagnostics hosts ‘International Gynecologic & Breast Cancer Symposium 2022’
By IPP Bureau - November 23, 2022
Timely screening and accurate detection through precision diagnostics, targeted therapy, risk reducing surgeries, and comprehensive multimodality treatment options have resulted in improving survival rates and quality of life in cancer patients in India
Ministry of Ayush announces setting up of Academic Chair at Western Sydney University
By IPP Bureau - November 23, 2022
It will undertake academic and collaborative research activities in Ayurveda, including herbal medicine and yoga, as well as design academic standards, short-term/medium-term courses, and educational guidelines
USFDA grants priority review of BLA for dengue vaccine TAK-003
By IPP Bureau - November 23, 2022
If approved, TAK-003 has the potential to become an important dengue prevention option for healthcare providers
Ajooni Biotech awarded ZED certification by Ministry of MSME
By IPP Bureau - November 22, 2022
The company will reduce wastage substantially, increase productivity, enhance environmental consciousness, save energy, optimally use natural resources, and expand its market penetration
